{"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"OTHER","otherAnalysisDescription":"Descriptive statistics were used to evaluate the prevalence and grade of xerostomia over time.\n\nMargin-based: Mean=1.14, SD=0.378, Range=1, 25th percentile=1, Median=1, 75th percentile=1, n=7 Robust: Mean=1.17, SD=0.577, Range=2, 25th percentile=1, Median=1, 75th percentile=1, n=12"}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.378","value":"1.14"},{"groupId":"OG001","spread":"0.577","value":"1.17"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"12"}],"units":"Participants"}],"description":"Self reported dry mouth using Late Effects Normal Tissue Task Force -Subjective, Objective, Management, Analytic (LENT/SOMA) scale. LENT/SOMA measures xerostomia in 4 stages. This ranges from Stage 1 \"occasional dryness\" through Stage 4 \"complete dryness, debilitating\". Lower stage values indicate a more favorable outcome than higher stage values.","dispersionType":"Standard Deviation","groups":[{"description":"This arm will receive Intensity-Modulated Radiation Therapy (IMRT) that was calculated by introducing a margin to the target area.\n\nMargin-Based Radiotherapy planning: Investigator will plan Intensity-Modulated Radiation Therapy (IMRT) using calculations that introduce a margin to the target area","id":"OG000","title":"Margin-Based Radiotherapy Planning"},{"description":"This arm will receive Intensity-Modulated Radiation Therapy (IMRT) that was calculated to minimize the dose of radiation to normal tissue.\n\nRobust Radiotherapy planning: Investigator will plan Intensity-Modulated Radiation Therapy (IMRT) using calculations that minimize the dose of radiation to normal tissue","id":"OG001","title":"Robust Radiotherapy Planning"}],"paramType":"MEAN","populationDescription":"There were missing data.","reportingStatus":"POSTED","timeFrame":"Baseline","title":"Grade of Xerostomia","type":"PRIMARY","unitOfMeasure":"units on a scale"}